Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009
Authors:
- The Madrid Cohort Of Hiv-Infected Mother-Infant PairsTPThe Madrid Cohort Of Hiv-Infected Mother-Infant Pairs
- Luis M PrietoLPLuis M Prieto
- María Isabel González- ToméMTMaría Isabel González- Tomé
- Eloy MuñozEMEloy Muñoz
- María Fernández-IbietaMFMaría Fernández-Ibieta
- Beatriz SotoBSBeatriz Soto
- Ana ÁlvarezAÁAna Álvarez
- Maria Luisa NavarroMNMaria Luisa Navarro
- Miguel Ángel RoaMRMiguel Ángel Roa
- José BeceiroJBJosé Beceiro
- María Isabel de JoséMJMaría Isabel de José
- Iciar OlabarrietaIOIciar Olabarrieta
Open Access
- 24 December 2014
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 700
Abstract
Antiretroviral therapy (ART) in pregnancy has resulted in a marked impact on reducing the risk of mother-to-child transmission (MCT) of HIV. However the safety of in utero ART exposure in newborns remains a concern. A multicenter prospective observational study of HIV-infected mother and their infants was performed in Madrid, Spain, from 2000 to 2009. Children had regular visits with clinical examination according to protocol until the age of 24 months. An abdominal ultrasound and an echocardiogram were scheduled during follow up. Birth defects (BDs) were registered according to European Surveillance of Congenital Anomalies (EUROCAT). A total of 897 live births from 872 mothers were included. Overall the birth defects prevalence observed was 6.9% (95% CI 5.4-9.1).The most commonly reported birth defects types were in genital organs and urinary system (19 cases, 30.6%) and cardiovascular system (17 cases, 27.4%). There was no increased risk for infants exposed in the first trimester to ARVs compared with unexposed infants. No significant associations were observed between exposure to any individual antiretroviral agent during pregnancy and birth defects A higher prevalence of BDs was observed, higher than previously reported. In utero exposure to ART was not proved to be a major risk factor of birth defects in infants. However the relatively small number of patients is a major limitation of this study.Keywords
This publication has 54 references indexed in Scilit:
- Preterm Birth and Congenital Heart Defects: A Population-based StudyPediatrics, 2012
- Prevalence of Congenital Anomalies in Infants With In Utero Exposure to AntiretroviralsThe Pediatric Infectious Disease Journal, 2012
- Postexposure Infant Prophylaxis in High-risk Situations of Human Immunodeficiency Virus Type 1 TransmissionThe Pediatric Infectious Disease Journal, 2012
- Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected WomenThe Pediatric Infectious Disease Journal, 2010
- Prevention of mother‐to‐child transmission of HIV in Denmark, 1994–2008HIV Medicine, 2010
- Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Vertical transmission of HIV in Belgium: a 1986–2002 retrospective analysisEuropean Journal of Pediatrics, 2008
- Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal CohortAIDS, 2008
- Safety of Agents Used to Prevent Mother-to-Child Transmission of HIVDrug Safety, 2007
- Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registryPharmacoepidemiology and Drug Safety, 2002